Skip to content

Insider · CIK 0001502785

Tasse Daniel

Reports to the SEC for 4 companies · ROCKVILLE, MD

Transactions

29

Companies

4

Filings

15

CIK

0001502785

Forms 4 and 5

Insider transactions

29 trades
DateCompanyValue
2026-05-29RGNXREGENXBIO Inc.A Award—
2026-05-29RGNXREGENXBIO Inc. · Stock Options (Right to Buy)A Award—
2025-11-21DBVTDBV Technologies S.A. · Employee Stock Option (right to buy)A Award—
2025-05-30RGNXREGENXBIO Inc.A Award—
2025-05-30RGNXREGENXBIO Inc. · Stock Options (Right to Buy)A Award—
2024-12-04DBVTDBV Technologies S.A. · Employee Stock Option (right to buy)A Award—
2024-05-31RGNXREGENXBIO Inc.A Award—
2024-05-31RGNXREGENXBIO Inc. · Stock Options (Right to Buy)A Award—
2024-03-08DBVTDBV Technologies S.A.P Purchase+$14.2K
2023-11-20DBVTDBV Technologies S.A. · Employee Stock Option (right to buy)A Award—
2023-06-02RGNXREGENXBIO Inc.A Award—
2023-06-02RGNXREGENXBIO Inc. · Stock Options (Right to Buy)A Award—
2022-11-21DBVTDBV Technologies S.A. · Employee Stock Option (right to buy)A Award—
2022-06-03RGNXREGENXBIO Inc.A Award—
2022-06-03RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award—
2021-11-22DBVTDBV Technologies S.A. · Employee Stock Option (right to buy)A Award—
2021-06-04RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award—
2020-05-29RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award—
2019-05-31RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award—
2018-06-21Bellerophon Therapeutics, Inc.A Award—
2018-06-05Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award+$86.8K
2018-05-25RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award—
2017-09-22Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award—
2017-06-28Bellerophon Therapeutics, Inc.A Award—
2017-05-24RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award—
2016-08-15RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award—
2016-06-17Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award—
2016-04-28Bellerophon Therapeutics, Inc.A Award—
2015-02-19Bellerophon Therapeutics, Inc.P Purchase+$300K

Recent filings

15